High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: Relationship with TNF-α levels

Digestive Diseases and Sciences

Volumn 49, Issue 2, 2004, Pages 275-280

  Giannini, Edoardo ^a   Romagnoli, Paola ^a   Tenconi, Gian Luca ^a   Botta, Federica ^a   Malfatti, Federica ^a   Chiarbonello, Bruno ^a   Mamone, Mario ^a   Barreca, Tommaso ^a   Testa, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Ascites; Leptin; Liver cirrhosis; Tumor necrosis factor

Indexed keywords

LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASCITES; ASCITES FLUID LEVEL; BACTERIAL PERITONITIS; BIOENERGY; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HOMEOSTASIS; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; IMPEDANCE; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL;

ADIPOSE TISSUE; AGED; ASCITES; ASCITIC FLUID; BODY COMPOSITION; BODY MASS INDEX; ELECTRIC IMPEDANCE; FEMALE; HUMANS; LEPTIN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642323907     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000017451.48031.b6     Document Type: Article

References (36)

1. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 395:763-770, 1998
2. Larsson H, Elmstahl S, Berglund G, Ahren B: Evidence for leptin regulation of food intake in humans. J Clin Endocrinol Metab 83:4382-4385, 1998
3. Mantzoros CS, Moschos SJ: Leptin: in search of role(s) in human physiology and pathophysiology. Clin Endocrinol 49:551-567, 1998
4. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
5. Mantzoros CS: The role of leptin in human obesity and disease: a review of the current evidence. Ann Intern Med 130:671-680, 1999
6. Greco AV, Mingrone G, Benedetti G, Capristo E, Tataranni PA, Gasbarrini G: Daily energy and substrate metabolism in patients with cirrhosis. Hepatology 27:346-350, 1998
7. Shimizu H, Kakizaki S, Tsuchiya T, Nagamine T, Takagi H, Takayama H, Kobayashi I, Mori M: An increase of circulating leptin in patients with liver cirrhosis. Int J Obes Relat Metab Disord 22:1234-1238, 1998
8. Henriksen JH, Hoist JJ, Moller S, Brinch K, Bendtsen F: Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Hepatology 29:1818-1824, 1999
9. McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC: Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 115:947-953, 1998
10. Testa R, Franceschini R, Giannini E, Cataldi A, Botta F, Fasoli A, Tenerelli P, Rolandi E, Barreca T: Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol 33:33-37, 2000.
11. Greco AV, Mingrone G, Favuzzi A, Capristo E, Gniuli D, Addolorato G, Brunani A, Cavagnin F, Gasbarrini G: Serum leptin levels in post-hepatitis liver cirrhosis. J Hepatol 33:38-42, 2000
12. Ben-Ari Z, Schafer Z, Sulkes J, Manhaim V, Tur-Kaspa R, Fainaru M: Alterations in serum leptin in chronic liver disease. Dig Dis Sci 47:183-189, 2002
13. Onodera K, Kato A, Suzuki K: Serum leptin concentrations in liver cirrhosis: relationship to the severity of liver dysfunction and their characteristic diurnal profiles. Hepatol Res 21:205-212, 2001
14. Zumbach MS, Boehme MW, Wahl P, Stremmel W, Ziegler R, Nawroth PP: Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 82:4080-4082, 1997
15. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782, 1997
16. Zhang HH, Kumar S, Barnett AH, Eggo MC: Tumor necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol 159:79-88, 2000
17. Finck BN, Johnson RW: Tumor necrosis factor-alpha regulates secretion of the adipocyte-derived cytokine, leptin. Microsc Res Tech 50:209-215, 2000
18. Widjaja A, Wedemeyer H, Tilmann HL, Horn R, Ockenga J, Jaeckel E, von zur Mühlen A, Manns MP, Brabant G: Hepatitis C and the leptin system. Bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy. Scand J Gastroenterol 36:426-431, 2001.
19. Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG, Hauner H: Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 28:690-693, 1996
20. van Harmelen V, Dicker A, Ryden M, Hauner H, Lonnqvist F, Naslund E, Arner P: Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 51:2029-2036, 2002
21. Heimburger O, Wang T, Lonnqvist F, Stenvinkel P: Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. Nephrol Dial Transplant 14:723-727, 1999
22. Navasa M, Follo A, Filella X, Jiménez W, Francitorra A, Planas R, Rimola A, Arroyo V, Rodés J: Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 27:1227-1232, 1998
23. Topley N, Jorres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, Muller C, Coles GA, Davies M, Williams JD: Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int 43:226-233, 1993
24. Topley N, Williams JD: Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int Suppl 48:S71-S78, 1994
25. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649, 1973
26. Selberg O, Selberg D: Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 86:509-516, 2002
27. Tsujimoto Y, Shoji T, Tabata T, Monta A, Emoto M, Nishizawa Y, Morii H: Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 34:832-838, 1999
28. Fontan MP, Rodriguez-Carmona A, Cordido F, Garcia-Buela J: Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: A comparative analysis. Am J Kidney Dis 34:824-831, 1999
29. Arkouche W, Juillard L, Delawari E, Lasne Y, Combarnous F, Sibai-Galland R, Traeger I, Laville M, Fouque D: Peritoneal clearance of leptin in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 34:839-844, 1999
30. Stenvinkel P, Heimburger O: The enigma of increasing serum leptin levels during peritoneal dialysis. Am J Kidney Dis 34:947-950, 1999
31. Rodriguez-Ramos C, Galan F, Diaz F, Elvira J, Martin-Herrera L, Giron-Gonzalez JA: Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci 46:1668-1676, 2001
32. Fawcett RL, Waechter AS, Williams LB, Zhang P, Louie R, Jones R, Inman M, Huse J, Considine RV: Tumor necrosis factor-alpha inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans. J Clin Endocrinol Metab 85:530-535, 2000
33. Santos-Alvarez J, Goberna R, Sanchez-Margalet V: Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194:6-11, 1999
34. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu Z, Ajami A, Weetman AP, Strasburger CJ, Ross RJ: High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 167:4593-4599, 2001
35. Bac DJ, Pruimboom WM, Mulder PG, Zijlstra FJ, Wilson JH: High interleukin-6 production within the peritoneal cavity in decompensated cirrhosis and malignancy-related ascites. Liver 15:265-270, 1995
36. Sanchez-Rodriguez A, Criado M, Flores O, Olveira-Martin A, Martin-Oterino JA, Esteller A: Correlation of high levels of hyaluronan and cytokines (IL-1beta, IL-6, and TGF-beta) in ascitic fluid of cirrhotic patients. Dig Dis Sci 45:2229-2232, 2000